Skip to main content

GOLDMAN SACHS GROUP INC

Position in GRAL — GRAIL, Inc.

CIK 886982 NEW YORK, NY

Position in GRAL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,066,983
+$20,993,151 QoQ
Shares Held
748,015
+28.5% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 374 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Dec 31, 2025
CallValue
$410,832
CallShares
4,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $7,059,039,871 across 32 Diagnostics & Research names. GRAL ranks #21 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,066,983 748,015
2026-03-31 $30,073,832 581,924
2025-12-31 $45,960,630 536,986
2025-12-31 $410,832 4,800
2025-09-30 $21,584,341 365,032
2025-06-30 $3,727,898 72,499
2025-03-31 $662,226 25,929
2024-12-31 $758,517 42,494
2024-09-30 $658,401 47,849